Centre accepts proposal to increase gap between 2 Covishield doses to 12-16 weeks

The Health Ministry on Thursday agreed to extend the gap between the two doses of the Covishield covid-19 vaccine to 12-16 weeks. The announcement came after the National Technical Advisory Group on Immunisation (NTAGI), an advisory group on the Covid-19 vaccines recommended this.

However, no change has been suggested for Bharat Biotech’s Covaxin, whose gap between the two doses stands at four to six weeks.

The government expert panel had also recommended those testing positive for coronavirus to defer vaccination for six months after recovery. Experts have also suggested that people who have received plasma during their treatment, they should get vaccinated at least after 12 weeks. But no clear decision has been announced on these.